Saratoga Research & Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $103M | Buy |
|
|||||
|
2025
Q2 | $104M | Buy |
|
|||||
|
2025
Q1 | $101M | Buy |
|
|||||
|
2024
Q4 | $60.3M | Sell |
|
|||||
|
2024
Q3 | $84.4M | Sell |
|
|||||
|
2024
Q2 | $107M | Sell |
|
|||||
|
2024
Q1 | $101M | Sell |
|
|||||
|
2023
Q4 | $85.6M | Sell |
|
|||||
|
2023
Q3 | $81M | Sell |
|
|||||
|
2023
Q2 | $74.1M | Sell |
|
|||||
|
2023
Q1 | $74.7M | Sell |
|
|||||
|
2022
Q4 | $91.8M | Sell |
|
|||||
|
2022
Q3 | $69.6M | Sell |
|
|||||
|
2022
Q2 | $78.8M | Sell |
|
|||||
|
2022
Q1 | $87.3M | Sell |
|
|||||
|
2021
Q4 | $89.4M | Sell |
|
|||||
|
2021
Q3 | $80.2M | Sell |
|
|||||
|
2021
Q2 | $104M | Buy |
|
|||||
|
2021
Q1 | $82.4M | Buy |
|
|||||
|
2020
Q4 | $81.6M | Buy |
|
|||||
|
2020
Q3 | $79.4M | Sell |
|
|||||
|
2020
Q2 | $77.7M | Sell |
|
|||||
|
2020
Q1 | $91.5M | Sell |
|
|||||
|
2019
Q4 | $88.7M | Sell |
|
|||||
|
2019
Q3 | $79.9M | Sell |
|
|||||
|
2019
Q2 | $79.1M | Buy |
|
|||||
|
2019
Q1 | $79M | Buy |
|
|||||
|
2018
Q4 | $66.2M | Sell |
|
|||||
|
2018
Q3 | $70.2M | Sell |
|
|||||
|
2018
Q2 | $70.2M | Sell |
|
|||||
|
2018
Q1 | $76.3M | Buy |
|
|||||
|
2017
Q4 | $81.1M | Buy |
|
|||||
|
2017
Q3 | $72M | Buy |
|
|||||
|
2017
Q2 | $62.9M | Buy |
|
|||||
|
2017
Q1 | $47.9M | Buy |
|
|||||
|
2016
Q4 | $45.5M | Buy |
|
|||||
|
2016
Q3 | $49.9M | Buy |
|
|||||
|
2016
Q2 | $42.9M | Buy |
|
|||||
|
2016
Q1 | $40.9M | Buy |
|
|||||
|
2015
Q4 | $34.1M | Sell |
|
|||||
|
2015
Q3 | $32.6M | Buy |
|
|||||
|
2015
Q2 | $32.9M | Sell |
|
|||||
|
2015
Q1 | $33.9M | Sell |
|
|||||
|
2014
Q4 | $30.4M | Sell |
|
|||||
|
2014
Q3 | $34.9M | Sell |
|
|||||
|
2014
Q2 | $35.8M | Sell |
|
|||||
|
2014
Q1 | $38.1M | Buy |
|
|||||
|
2013
Q4 | $30.3M | Buy |
|
|||||
|
2013
Q3 | $24.7M | Sell |
|
|||||
|
2013
Q2 | $23.1M | Buy |
|